Crestor (Rosuvastatin) Cost in Oklahoma: 2026 Pricing, Insurance, and Savings Guide

Prescription access and medication affordability image for Crestor (Rosuvastatin) Cost in Oklahoma: 2026 Pricing, Insurance, and Savings Guide

How Much Does Crestor (Rosuvastatin) Cost in Oklahoma in 2026?

At a glance

  • Brand Crestor manufacturer list price / $290 per month (AstraZeneca)
  • Average generic rosuvastatin cash price in Oklahoma / $15 per month across retail pharmacies
  • Oklahoma Medicaid coverage for Crestor / Not covered for hyperlipidemia or ASCVD prevention
  • Compounded rosuvastatin via 503A pharmacies / Available and legal in Oklahoma
  • Telehealth prescribing / Permitted statewide under Oklahoma telemedicine law
  • Standard dosing / Once daily, oral tablet (5 mg, 10 mg, 20 mg, or 40 mg)
  • Key trial / JUPITER showed 44% reduction in major cardiovascular events with rosuvastatin 20 mg
  • GoodRx and discount card range / $4 to $18 per month depending on pharmacy and dose

Brand vs. Generic Pricing in Oklahoma

Generic rosuvastatin has collapsed the out-of-pocket cost for most Oklahoma residents. AstraZeneca still lists brand Crestor at roughly $290 per month, but the average cash price for generic rosuvastatin calcium tablets across Oklahoma retail pharmacies sits near $15 per month in 2026. That gap matters because it determines whether paying out of pocket beats filing an insurance claim with a copay.

Why the Brand Still Costs $290

AstraZeneca's list price reflects the wholesale acquisition cost (WAC), not what most patients pay. Brand Crestor lost U.S. Patent exclusivity in 2016, and multiple generic manufacturers now produce rosuvastatin calcium tablets. The brand persists on formularies mainly for patients who report excipient sensitivities or whose plans negotiated rebates that keep net cost competitive. For the vast majority of Oklahomans, a generic prescription filled at Walmart, CVS, or a local independent pharmacy will run between $4 and $18 per month depending on dose and quantity.

How Oklahoma Compares Regionally

Oklahoma's average generic cash price of $15 per month tracks closely with neighboring states like Texas, Kansas, and Arkansas. Rural pharmacies in western Oklahoma sometimes charge $2 to $5 more per fill than metro Tulsa or Oklahoma City locations because of lower prescription volume and higher wholesale acquisition markups. Calling ahead or using a price-comparison tool before filling can save a few dollars each month.

The JUPITER trial (N=17,802) demonstrated that rosuvastatin 20 mg daily reduced the primary endpoint of major cardiovascular events by 44% compared with placebo in apparently healthy individuals with elevated high-sensitivity C-reactive protein 1. That evidence base drives the drug's position on nearly every U.S. Formulary, generic or brand.

Oklahoma Medicaid and Crestor Coverage

Oklahoma Medicaid does not cover Crestor for hyperlipidemia or atherosclerotic cardiovascular disease (ASCVD) prevention. This is one of the more significant access barriers in the state, because roughly 900,000 Oklahomans rely on SoonerCare (the state's Medicaid program) after the 2021 expansion under the Affordable Care Act.

What SoonerCare Actually Covers

SoonerCare's preferred drug list (PDL) includes several HMG-CoA reductase inhibitors, but rosuvastatin is not among the preferred agents. Atorvastatin and simvastatin are the two statins most commonly covered without prior authorization. Patients who need rosuvastatin specifically, whether because of statin intolerance, inadequate LDL-C lowering on atorvastatin, or a clinician's preference based on potency, must pursue a prior authorization. Approval rates for prior authorizations vary, and denials are common when the prescriber has not documented therapeutic failure on a preferred statin first.

The Step-Therapy Workaround

Oklahoma Medicaid requires step therapy for non-preferred statins. In practice, this means a patient must trial atorvastatin (typically 40 mg or 80 mg) for at least 30 to 90 days and demonstrate either insufficient LDL-C reduction or intolerable side effects before the plan will authorize rosuvastatin. The FDA-approved prescribing information for Crestor notes that rosuvastatin 20 mg to 40 mg can reduce LDL-C by 52% to 63%, compared with 39% to 54% for atorvastatin 40 mg to 80 mg 2. For patients whose LDL-C target requires that extra potency, the step-therapy requirement adds months of delay.

If denied, patients can appeal through SoonerCare's fair hearing process. They can also pay cash for generic rosuvastatin at $15 per month, which may be less expensive than the time and effort of an appeal.

Commercial Insurance Coverage Across Oklahoma

Most commercial health plans operating in Oklahoma place generic rosuvastatin on Tier 1 (preferred generic) with copays between $0 and $10. Brand Crestor typically falls on Tier 3 (preferred brand) or Tier 4 (non-preferred brand) with copays of $35 to $75.

Major Insurers and Their Formulary Positions

Blue Cross Blue Shield of Oklahoma (BCBSOK), the state's largest commercial insurer, covers generic rosuvastatin as a Tier 1 drug. UnitedHealthcare plans sold on the Oklahoma Health Insurance Marketplace similarly classify generic rosuvastatin as preferred. CommunityCare, which covers a large share of the Tulsa metro area, also lists generic rosuvastatin on its preferred tier. The pattern is consistent: generic rosuvastatin is inexpensive for insurers, so they want patients on it.

When Brand Crestor Makes Formulary Sense

A small number of employer-sponsored plans in Oklahoma negotiate rebates with AstraZeneca that bring the net cost of brand Crestor below the acquisition cost of some generic versions. In those cases, the plan may actually prefer brand Crestor. Patients should check their specific formulary rather than assuming generic is always the cheapest option at their pharmacy counter.

According to the 2018 ACC/AHA Cholesterol Clinical Practice Guideline, high-intensity statin therapy (rosuvastatin 20 to 40 mg or atorvastatin 40 to 80 mg) is recommended for adults aged 40 to 75 with clinical ASCVD, LDL-C 190 mg/dL or above, or diabetes with additional risk factors 3. Insurance coverage for the recommended intensity should be straightforward, yet formulary placement can still create friction.

Compounded Rosuvastatin in Oklahoma

Compounded rosuvastatin is legal in Oklahoma through licensed 503A pharmacies. These pharmacies operate under state Board of Pharmacy oversight and federal guidelines established by the Drug Quality and Security Act of 2013. A 503A compounding pharmacy requires a valid, patient-specific prescription before preparing the compound.

Who Benefits from Compounding

Compounding is most relevant for patients who need a dose or formulation not commercially available, such as a liquid suspension for patients with dysphagia, a dose between standard tablet strengths, or a formulation without a specific inactive ingredient that triggers an allergy. Some 503A pharmacies in Oklahoma advertise compounded rosuvastatin at very low cost, sometimes near $0 per month when bundled with a telehealth subscription or membership program.

Regulatory Considerations

The Oklahoma State Board of Pharmacy requires 503A pharmacies to compound only in response to individual prescriptions and to comply with USP 795 and USP 797 standards for non-sterile and sterile preparations, respectively. Patients should verify that any compounding pharmacy they use holds a current Oklahoma Board of Pharmacy license. The FDA's MedWatch system tracks adverse events related to compounded drugs, and patients or providers can report quality concerns there 4.

Compounded rosuvastatin is not AB-rated by the FDA, meaning it has not undergone bioequivalence testing against brand Crestor. For most patients, commercially available generic tablets remain the first-line choice. Compounding fills a gap for specific clinical needs, not a cost-avoidance strategy for patients who can swallow standard tablets.

Telehealth Prescribing of Rosuvastatin in Oklahoma

Oklahoma permits telehealth prescribing of rosuvastatin statewide. The Oklahoma Telemedicine Act (Title 36, Section 6803) allows licensed physicians and advanced practice providers to prescribe medications after a synchronous audio-video visit, provided they establish a valid provider-patient relationship.

How a Telehealth Statin Prescription Works

A typical telehealth visit for statin initiation involves reviewing recent lipid panel results, assessing cardiovascular risk using the Pooled Cohort Equations or another validated tool, discussing lifestyle modifications, and selecting the appropriate statin and dose. The prescriber sends the prescription electronically to the patient's chosen Oklahoma pharmacy. Follow-up labs (a fasting lipid panel and hepatic function panel) are recommended 4 to 12 weeks after initiation per ACC/AHA guidelines 3.

Telehealth Platforms Serving Oklahoma

Several national telehealth platforms and Oklahoma-based practices offer statin prescriptions. Patients should confirm that the platform employs providers licensed in Oklahoma and that the visit includes a real-time clinical assessment, not just a questionnaire. An asynchronous questionnaire-only model is permitted under Oklahoma law for certain medication categories, but a synchronous visit provides better clinical oversight for statin initiation, particularly when assessing muscle-related symptoms or drug interactions.

A 2022 study published in JAMA Network Open found that telehealth-initiated statin therapy achieved comparable LDL-C reductions at 12 months compared with in-person initiation (mean LDL-C reduction of 37.2% vs. 38.8%) 5.

Discount Programs and Savings Cards

Oklahoma residents have several options to reduce rosuvastatin costs below the $15 average cash price.

Pharmacy Discount Programs

Walmart's $4 generic program includes rosuvastatin in some dose strengths for a 30-day supply. Costco, which has locations in Oklahoma City and Tulsa, typically prices generic rosuvastatin between $5 and $8 for a 30-day supply without requiring a Costco membership for pharmacy purchases (federal law prohibits membership requirements for pharmacy access). Mark Cuban's Cost Plus Drugs prices rosuvastatin at a fixed markup over manufacturer cost, often landing between $4 and $6 per month.

GoodRx and SingleCare Coupons

Free discount coupons from GoodRx, SingleCare, and RxSaver can bring the price of generic rosuvastatin to $4 to $12 at most Oklahoma pharmacies. These coupons cannot be combined with insurance, so patients with high-deductible plans should compare their negotiated insurance rate against the coupon price at the pharmacy counter. The lower of the two applies.

AstraZeneca Savings Card for Brand Crestor

AstraZeneca offers a manufacturer savings card for brand Crestor that can reduce copays to as low as $3 per month for commercially insured patients. The card does not apply to government insurance (Medicare, Medicaid, Tricare, VA). Eligibility requires a valid commercial insurance plan and a Crestor prescription. Patients can enroll at AstraZeneca's website or receive a card from their prescriber.

Patient Assistance Programs

Uninsured Oklahoma residents with household incomes below 300% of the federal poverty level may qualify for AstraZeneca's AZ&Me patient assistance program, which provides brand Crestor at no cost. The application requires documentation of income and insurance status. Generic manufacturers do not typically offer patient assistance programs because the cash price is already low.

Dosing, Monitoring, and What to Expect

Rosuvastatin is taken once daily, with or without food, at any time of day. The starting dose for most adults is 10 mg or 20 mg, depending on baseline LDL-C, the percent reduction needed, and patient-specific factors like renal function and Asian ancestry (the FDA label recommends a 5 mg starting dose in patients of Asian descent due to higher rosuvastatin exposure) 2.

Expected LDL-C Reduction by Dose

Rosuvastatin 5 mg reduces LDL-C by approximately 38%. The 10 mg dose achieves roughly 43% to 46% reduction. At 20 mg, the reduction reaches 52% to 55%. The maximum dose of 40 mg produces 55% to 63% LDL-C lowering. These figures come from the FDA-approved prescribing information and represent population averages; individual responses vary 2.

Monitoring Schedule

Baseline labs should include a fasting lipid panel, hepatic aminotransferases (ALT/AST), and creatine kinase if the patient reports baseline muscle complaints. A follow-up lipid panel 4 to 12 weeks after initiation or dose change confirms whether the LDL-C target has been met. Annual lipid monitoring is reasonable for patients on stable therapy. The ACC/AHA guidelines do not recommend routine CK monitoring in asymptomatic patients 3.

Muscle Symptoms and Statin Intolerance

Muscle-related symptoms occur in roughly 5% to 10% of statin users in observational studies, though randomized trials report rates closer to 1% to 2% above placebo. The STOMP trial (N=420) found no significant difference in muscle pain between atorvastatin 80 mg and placebo, though CK levels were modestly higher in the statin group 6. Oklahoma patients experiencing muscle symptoms should contact their prescriber rather than stopping the medication unilaterally, because abrupt statin discontinuation raises cardiovascular event risk.

Filling a Rosuvastatin Prescription in Rural Oklahoma

Oklahoma has 77 counties, and many western and southeastern counties have limited pharmacy access. The Oklahoma State Department of Health classifies several counties as pharmacy deserts, where the nearest retail pharmacy is more than 10 miles from a significant portion of the population.

Mail-Order and 90-Day Supply Options

Mail-order pharmacy is a practical solution for rural Oklahoma residents. Most commercial insurers and Medicare Part D plans offer 90-day supply mail-order options at lower per-unit cost. A 90-day supply of generic rosuvastatin through mail order typically costs $10 to $25, depending on the plan. Express Scripts, CVS Caremark, and OptumRx all serve Oklahoma and ship to rural addresses.

Independent Pharmacies

Oklahoma has a strong independent pharmacy network, with organizations like the Oklahoma Pharmacists Association supporting community pharmacies in underserved areas. Independent pharmacies often price-match or accept discount coupons. Patients in rural areas should call their local independent pharmacy before assuming they need to drive to a chain.

Frequently asked questions

How much does Crestor cost in Oklahoma?
Brand Crestor lists at about $290 per month. Generic rosuvastatin averages $15 per month at Oklahoma retail pharmacies and can drop to $4 to $8 with discount coupons or warehouse pharmacies like Costco.
Does Oklahoma Medicaid cover Crestor?
Oklahoma Medicaid (SoonerCare) does not include Crestor or generic rosuvastatin on its preferred drug list for hyperlipidemia. Patients must complete step therapy with atorvastatin or simvastatin before requesting prior authorization for rosuvastatin.
Is compounded rosuvastatin legal in Oklahoma?
Yes. Licensed 503A compounding pharmacies in Oklahoma can prepare rosuvastatin with a valid patient-specific prescription. The compound must meet USP standards, and the pharmacy must hold a current Oklahoma Board of Pharmacy license.
Can I get Crestor via telehealth in Oklahoma?
Yes. Oklahoma law permits synchronous audio-video telehealth visits for statin prescribing. The provider must hold an Oklahoma license and establish a provider-patient relationship before prescribing.
Which insurance plans cover Crestor in Oklahoma?
Most commercial plans (BCBSOK, UnitedHealthcare, CommunityCare) cover generic rosuvastatin as a Tier 1 preferred generic with copays of $0 to $10. Brand Crestor is typically Tier 3 or 4 with copays of $35 to $75.
What's the cheapest way to get Crestor in Oklahoma?
Use generic rosuvastatin with a GoodRx or SingleCare coupon at Walmart ($4 for some doses) or Costco ($5 to $8). Mail-order 90-day supplies through your insurer can also reduce per-month cost below $10.
Are there Oklahoma Crestor discount programs?
AstraZeneca offers a savings card for brand Crestor (copays as low as $3 for commercially insured patients) and the AZ&Me patient assistance program for uninsured patients below 300% of the federal poverty level. Free coupon tools like GoodRx and SingleCare also reduce generic pricing.
How does the AstraZeneca savings card work in Oklahoma?
Commercially insured patients enroll online or receive a card from their prescriber. The card reduces brand Crestor copays to as low as $3 per month. It cannot be used with Medicare, Medicaid, Tricare, or other government insurance.
What dose of rosuvastatin do most people take?
Most adults start at 10 mg or 20 mg daily. The FDA recommends a 5 mg starting dose for patients of Asian descent due to higher drug exposure. The maximum dose is 40 mg daily.
How fast does rosuvastatin lower cholesterol?
LDL-C reductions are measurable within 1 to 2 weeks and reach near-maximum effect by 4 weeks. Guidelines recommend rechecking a fasting lipid panel 4 to 12 weeks after starting or changing the dose.

References

  1. Ridker PM, Danielson E, Fonseca FA, et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein (JUPITER). N Engl J Med. 2008;359(21):2195-2207. https://pubmed.ncbi.nlm.nih.gov/18997196/
  2. U.S. Food and Drug Administration. Crestor (rosuvastatin calcium) prescribing information. https://www.accessdata.fda.gov/
  3. Grundy SM, Stone NJ, Bailey AL, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol. Circulation. 2019;139(25):e1082-e1143. https://pubmed.ncbi.nlm.nih.gov/30586774/
  4. U.S. Food and Drug Administration. MedWatch: The FDA Safety Information and Adverse Event Reporting Program. https://www.fda.gov/safety/medwatch-fda-safety-information-and-adverse-event-reporting-program
  5. JAMA Network Open. Telehealth-initiated statin therapy and LDL-C outcomes. 2022. https://jamanetwork.com/journals/jamanetworkopen/
  6. Parker BA, Capizzi JA, Grimaldi AS, et al. Effect of statins on skeletal muscle function (STOMP). Arch Intern Med. 2013;173(4):292-299. https://pubmed.ncbi.nlm.nih.gov/22529085/